OP-2507 101758-79-6 Cyclopenta[b]pyrrole-2-pentanoic acid, 3,3a,4,5,6,6a-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-3-(cis-4-propylcyclohexyl)-1-propen-1-yl]-, methylester, (3aR,4R,5R,6aS)-;Cyclopenta[b]pyrrole-2-pentanoic acid, 3,3a,4,5,6,6a-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-3-(cis-4-propylcyclohexyl)-1-propen-1-yl]-, methylester, (3aR,4R,5R,6aS)-
| CAS 号 | 101758-79-6 |
| 分子式 | C25H41NO4 |
| 分子量 | 419.60 g/mol |
| 分类 | 药物标准品 / 原料药标准品 |
| 库存状态 | 现货 |
本产品为药物标准品(OP-2507 101758-79-6 Cyclopenta[b]pyrrole-2-pentanoic acid, 3,3a,4,5,6,6a-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-3-(cis-4-propylcyclohexyl)-1-propen-1-yl]-, methylester, (3aR,4R,5R,6aS)-;Cyclopenta[b]pyrrole-2-pentanoic acid, 3,3a,4,5,6,6a-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-3-(cis-4-propylcyclohexyl)-1-propen-1-yl]-, methylester, (3aR,4R,5R,6aS)-,CAS 101758-79-6),分子式 C25H41NO4,分子量 419.60。纯度 97%+。适用于分析方法开发、方法验证及日常质检,CATO 提供全程冷链与全球配送。
的产生途径与其化学式中甾体骨架,酰胺类,含羟基,含醚键密切相关,该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 (OP-2507 101758-79-6 Cyclopentabpyrrole-2-pentanoic acid, 3,3a,4,5,6,6a-hexahydro-5-hydroxy-4-(1E,3S)-3-hydroxy-3-(cis-4-propylcyclohexyl)-1-propen-1-yl-, methylester, (3aR,4R,5R,6aS)-;Cyclopentabpyrrole-2-pentanoic acid, 3,3a,4,5,6,6a-hexahydro-5-hydroxy-4-(1E,3S)-3-hydroxy-3-(cis-4-propylcyclohexyl)-1-propen-1-yl-, methylester, (3aR,4R,5R,6aS)-),CAS注册编号 101758-79-6,化学分子式为 C25H41NO4,分子量 419.60 g/mol。 受分子结构中甾体骨架,酰胺类,含羟基,含醚键
应用场景:(OP-2507 101758-79-6 Cyclopenta b pyrrole-2-pentanoic acid, 3,3a,4,5,6,6a-hexahydro-5-hydroxy-4- (1E,3S)-3-hydroxy-3-(cis-4-propylcyclohexyl)-1-propen-1-yl -, methylester, (3aR,4R,5R,6aS)-;Cyclopenta b pyrrole-2-pentanoic acid, 3,3a,4,5,6,6a-hexahydro-5-hydroxy-4- (1E,3S)-3-hydroxy-3-(cis-4-propylcy
| 中文名称 | |
| 分子式 | C25H41NO4 |
| 分子量 | 419.60 g/mol |
| 外观形态 | 类白色至淡黄色结晶性粉末 |
| 纯度 | 97%+ |
| 储存条件 | 室温保存,避光,密封防潮 |
| 溶解性参考 | 可溶于甲醇、乙腈、DMSO、水(微溶) |
| 稳定性 | 空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射 |
| 化合物类型 | 药物标准品 |
| 子类 | 原料药标准品 |
| 不饱和度(DBE) | 6.0 |
| UV特征 | 有紫外吸收 |
| 结构特征 | 含芳环 |
| CAS登记年份(估) | 1986年 |
| 含氮原子数 | 1 |